RaQualia Pharma Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From

Takeda Pharmaceutical Co. Ltd. has entered into a final agreement with Altos Therapeutics to develop and commercialize globally the small US firm's gastroparesis candidate ATC-1906, along with an ex

While the initial image might be one of robots moving test tubes around or some intransigent HAL-like computer questioning human commands, the reality of applying artificial intelligence (AI) to drug

RaQualia Pharma sees a new collaboration with Nagoya University as having two main benefits: aiding its effort to find innovative new drugs and helping to control operational expenses. The Japanese ve